Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term 'Endogenous substance transport' refers broadly to the physiological process by which endogenous molecules such as nutrients, metabolites, ions, and signaling compounds are moved across cellular membranes via specialized membrane transporter proteins. These transporters belong to superfamilies such as the ATP-binding cassette (ABC) and solute carrier (SLC) families and are essential for maintaining cellular and systemic homeostasis, regulating metabolic pathways, protecting sensitive tissues, and modulating pharmacokinetics of drugs. As this is a process and not a distinct molecular entity, it is not considered a direct therapeutic target itself, though many specific endogenous substance transporters (e.g., P-glycoprotein, organic cation transporters) are individually validated drug targets and are associated with disease mechanisms ranging from cancer resistance to metabolic and neurodegenerative disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endogenous substance transport.